Protara Therapeutics TARA
NASDAQ TARA
$2.62 +0.19 (+7.82%)
At close: Nov 11, 2026 · 4:00 PM EST

Protara Therapeutics (TARA) Other Operating Expenses (2022)

Updated

Protara Therapeutics (TARA) posted Other Operating Expenses of $29.52 million for Q4 2022.

Analysis

Protara Therapeutics (TARA) Other Operating Expenses (2022) Analysis & Trends

  • In prior years, Protara Therapeutics' Other Operating Expenses was -$2.9 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Protara Therapeutics 149.62 Mn -411.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 29.52 Mn
API Access

Protara Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=TARA&period=max&api_key=YOUR_API_KEY